Adults with type 2 diabetes who switched from basal insulin therapy to insulin glargine injection experienced similar numbers of hypoglycemia events and decreases in average HbA1c as those who switched to insulin degludec. READ MORE

News

Adults with type 2 diabetes who switched from basal insulin therapy to insulin glargine injection experienced similar numbers of hypoglycemia events and decreases in average HbA1c as those who switched to insulin degludec.

READ MORE

Approximately 5.6% of new cancer cases worldwide are attributable to the combined effect of diabetes and a high body mass index.

READ MORE

The Blue Cross Blue Shield Association has announced a partnership with a Google-affiliated company to provide personalized type 2 diabetes care to members of its health plans.

READ MORE

Heart failure patients may be less likely to be hospitalized or die prematurely if they don’t also have diabetes – but even if they do have it, they may still minimize their risk by controlling their blood sugar.

READ MORE

Research in Review

A biomarker screening pathway for monogenic diabetes is an effective and easy approach to systematically screening young-onset patients.

READ MORE

Continuous subcutaneous insulin infusion is associated with increased hypoglycemia encounters and health care expenditures.

READ MORE

Researchers compared angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers for protecting type 2 diabetes patients.

READ MORE

Bariatric surgery is more effective than standard medical treatment for the long-term control of type 2 diabetes in obese patients.

READ MORE

Resources

According to a recent clinical practice guideline, the management of type 2 diabetes should include shared decision-making, individualized diabetes self-management education, and individualized glycemic management plans.

READ MORE